Advertisement
Home »

Long-Term Treatment With Sacubitril/Valsartan in Japanese Patients With Chronic Heart Failure and Reduced Ejection Fraction - Open-Label Extension of the PARALLEL-HF Study.

Aug 28, 2023

ABOUT THE EXPERTS

  • Hiroyuki Tsutsui

    Department of Cardiovascular Medicine, Faculty of Medical Sciences, Kyushu University.

    Shin-Ichi Momomura

    Saitama Citizens Medical Center.

    Yoshihiko Saito

    Nara Prefecture Seiwa Medical Center.

    Hiroshi Ito

    Department of General Internal Medicine 3, Kawasaki Medical School.

    Kazuhiro Yamamoto

    Department of Cardiovascular Medicine and Endocrinology and Metabolism, Tottori University.

    Yasushi Sakata

    Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine.

    Tomomi Ohishi

    Novartis Pharma K.K.

    Pankaj Kumar

    Novartis Pharma AG.

    Toshihito Kitamura

    Novartis Pharma K.K.

REFERENCES & ADDITIONAL READING

PubMed

MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.


Advertisement
Advertisement
ad
ad
MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.

SUBSCRIBE NOW

View all newsletters

Advertisement